Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
09/02/202323:55PR Newswire (US)Oramed Pharmaceuticals Issues Shareholder UpdateNASDAQ:ORMPOramed Pharmaceuticals Inc
12/01/202312:00PR Newswire (US)Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 DiabetesNASDAQ:ORMPOramed Pharmaceuticals Inc
04/01/202323:55PR Newswire (US)Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of DiabetesNASDAQ:ORMPOramed Pharmaceuticals Inc
04/01/202323:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
22/12/202200:25PR Newswire (US)Oramed Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
12/12/202223:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
30/11/202200:40PR Newswire (US)Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and MetabolismNASDAQ:ORMPOramed Pharmaceuticals Inc
18/11/202221:43TipRanksOramed Pharma Up After Positive Clinical DataNASDAQ:ORMPOramed Pharmaceuticals Inc
18/11/202204:26PR Newswire (US)Oramed Announces Additional Positive Safety and Efficacy Data from Its Phase 2 Clinical Trial of ORMD-0801 for NASHNASDAQ:ORMPOramed Pharmaceuticals Inc
14/11/202223:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
14/11/202223:55PR Newswire (US)Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South KoreaNASDAQ:ORMPOramed Pharmaceuticals Inc
11/11/202208:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
11/11/202208:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
11/11/202208:30PR Newswire (US)Oramed Reports Third Quarter 2022 Financial ResultsNASDAQ:ORMPOramed Pharmaceuticals Inc
10/11/202200:40PR Newswire (US)Oramed to Host Webinar Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASHNASDAQ:ORMPOramed Pharmaceuticals Inc
07/10/202223:40PR Newswire (US)Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 VaccineNASDAQ:ORMPOramed Pharmaceuticals Inc
13/09/202222:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
13/09/202222:40PR Newswire (US)Oramed Reports Positive Top-Line Results from Phase 2 NASH Trial with its ORMD-0801, Oral Insulin CandidateNASDAQ:ORMPOramed Pharmaceuticals Inc
09/09/202207:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/09/202221:55PR Newswire (US)Oramed to Present at H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
15/08/202220:50TipRanksAnalysts Offer Insights on Healthcare Companies: Precision BioSciences (DTIL) and Oramed Pharmaceuticals (ORMP)NASDAQ:ORMPOramed Pharmaceuticals Inc
11/08/202206:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
11/08/202206:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
02/08/202220:16TipRanksAnalysts Offer Insights on Healthcare Companies: Kazia Therapeutics (KZIA), EyePoint Pharmaceuticals (EYPT) and Oramed Pharmaceuticals (ORMP)NASDAQ:ORMPOramed Pharmaceuticals Inc
26/07/202221:55PR Newswire (US)Oramed Reaches 50% Enrollment in its Second Phase 3 Oral Insulin TrialNASDAQ:ORMPOramed Pharmaceuticals Inc
13/07/202207:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ORMPOramed Pharmaceuticals Inc
11/07/202221:55PR Newswire (US)Oramed to Present at the Upcoming Canaccord Genuity Annual Growth ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
11/07/202220:15TipRanksAnalysts Offer Insights on Healthcare Companies: MacroGenics (MGNX), KalVista Pharmaceuticals (KALV) and Oramed Pharmaceuticals (ORMP)NASDAQ:ORMPOramed Pharmaceuticals Inc
07/07/202222:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
07/07/202221:55PR Newswire (US)Oramed Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP

Your Recent History

Delayed Upgrade Clock